PI
AZN icon

PEAK6 Investments’s AstraZeneca AZN Stock Holding History

PEAK6 Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,500
Closed -$202K – 4029
2023
Q4 		$202K Buy
+1,500
New +$195K ﹤0.01% 3245
2023
Q1 		– Sell
-35,400
Closed -$4.8M – 4250
2022
Q4 		$4.8M Sell
35,400
-6,650
-16% -$834K 0.03% 748
2022
Q3 		$4.61M Buy
42,050
+15,150
+56% +$1.92M 0.02% 884
2022
Q2 		$3.56M Sell
26,900
-63,550
-70% -$8.34M 0.01% 1711
2022
Q1 		$12M Buy
90,450
+56,950
+170% +$6.83M 0.03% 609
2021
Q4 		$3.9M Sell
33,500
-167,350
-83% -$19.7M 0.01% 1320
2021
Q3 		$24.1M Buy
200,850
+146,800
+272% +$17.1M 0.05% 311
2021
Q2 		$6.47M Buy
54,050
+19,700
+57% +$2.16M 0.02% 923
2021
Q1 		$3.42M Buy
34,350
+24,350
+244% +$2.45M 0.01% 1375
2020
Q4 		$1M Buy
+10,000
New +$1.06M ﹤0.01% 2483
2020
Q3 		– Sell
-6,950
Closed -$735K – 4356
2020
Q2 		$735K Buy
6,950
+3,450
+99% +$356K ﹤0.01% 2356
2020
Q1 		$313K Sell
3,500
-149,250
-98% -$14.1M ﹤0.01% 2460
2019
Q4 		$15.2M Sell
152,750
-41,950
-22% -$3.95M 0.08% 256
2019
Q3 		$17.4M Buy
194,700
+63,800
+49% +$5.53M 0.11% 189
2019
Q2 		$10.8M Sell
130,900
-23,650
-15% -$1.85M 0.07% 329
2019
Q1 		$12.5M Sell
154,550
-75,850
-33% -$5.98M 0.07% 292
2018
Q4 		$17.5M Sell
230,400
-87,200
-27% -$6.81M 0.11% 174
2018
Q3 		$25.1M Buy
+317,600
New +$24M 0.11% 175

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6 Investments's AZN Position: Q3 2024 in Review

PEAK6 Investments increased its AstraZeneca (AZN) stake by 16% in Q3 2024, buying an estimated $202K and bringing the position to 9,001 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

PEAK6 Investments first reported a position in AZN in Q1 2020 and has held it in 12 quarters since. The position peaked at $4.79M in Q3 2022. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

  • PEAK6 Investments held 9,001 shares of AstraZeneca worth $1.4M as of Q3 2024.
  • PEAK6 Investments bought 1,251 AstraZeneca shares in Q3 2024, an estimated $202K.
  • AstraZeneca made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #1708 holding.
  • PEAK6 Investments first reported a position in AstraZeneca in Q1 2020 and has held it in 12 quarters since.
  • PEAK6 Investments's AstraZeneca position peaked at $4.79M in Q3 2022.
  • 1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.